|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li J, Wientjes MG and Au JL: Pancreatic
cancer: Pathobiology, treatment options, and drug delivery. AAPS J.
12:223–232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ranger GS: Current concepts in colorectal
cancer prevention with cyclooxygenase inhibitors. Anticancer Res.
34:6277–6282. 2014.PubMed/NCBI
|
|
5
|
Fajardo AM and Piazza GA: Chemoprevention
in gastrointestinal physiology and disease. Anti-inflammatory
approaches for colorectal cancer chemoprevention. Am J Physiol
Gastrointest Liver Physiol. 309:G59–G70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ristimäki A, Sivula A, Lundin J, Lundin M,
Salminen T, Haglund C, Joensuu H and Isola J: Prognostic
significance of elevated cyclooxygenase-2 expression in breast
cancer. Cancer Res. 62:632–635. 2002.PubMed/NCBI
|
|
7
|
Kondo M, Yamamoto H, Nagano H, Okami J,
Ito Y, Shimizu J, Eguchi H, Miyamoto A, Dono K, Umeshita K, et al:
Increased expression of COX-2 in nontumor liver tissue is
associated with shorter disease-free survival in patients with
hepatocellular carcinoma. Clin Cancer Res. 5:4005–4012.
1999.PubMed/NCBI
|
|
8
|
Masunaga R, Kohno H, Dhar DK, Ohno S,
Shibakita M, Kinugasa S, Yoshimura H, Tachibana M, Kubota H and
Nagasue N: Cyclooxygenase-2 expression correlates with tumor
neovascularization and prognosis in human colorectal carcinoma
patients. Clin Cancer Res. 6:4064–4068. 2000.PubMed/NCBI
|
|
9
|
Xu B, Wang Y, Yang J, Zhang Z, Zhang Y and
Du H: Celecoxib induces apoptosis but up-regulates VEGF via
endoplasmic reticulum stress in human colorectal cancer in vitro
and in vivo. Cancer Chemother Pharmacol. 77:797–806. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao Y, Teng Y, Zhang R and Luo L:
Antitumor effect of the selective COX-2 inhibitor celecoxib on
endometrial adenocarcinoma in vitro and in vivo. Oncol Lett.
4:1219–1224. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Netten JP, Cann SA and van der
Westhuizen NG: Angiogenesis and tumor growth. N Engl J Med.
334:920–921. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsujii M, Kawano S, Tsuji S, Sawaoka H,
Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced
by colon cancer cells. Cell. 93:705–716. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu XH, Kirschenbaum A, Yao S, Lee R,
Holland JF and Levine AC: Inhibition of cyclooxygenase-2 suppresses
angiogenesis and the growth of prostate cancer in vivo. J Urol.
164:820–825. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma X, Aoki T, Tsuruyama T and Narumiya S:
Definition of prostaglandin E2-EP2 signals in the colon tumor
microenvironment that amplify inflammation and tumor growth. Cancer
Res. 75:2822–2832. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eibl G, Bruemmer D, Okada Y, Duffy JP, Law
RE, Reber HA and Hines OJ: PGE(2) is generated by specific COX-2
activity and increases VEGF production in COX-2-expressing human
pancreatic cancer cells. Biochem Biophys Res Commun. 306:887–897.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wilson JS, Pirola RC and Apte MV: Stars
and stripes in pancreatic cancer: Role of stellate cells and stroma
in cancer progression. Front Physiol. 5:522014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Coffman LG, Choi YJ, McLean K, Allen BL,
di Magliano MP and Buckanovich RJ: Human carcinoma-associated
mesenchymal stem cells promote ovarian cancer chemotherapy
resistance via a BMP4/HH signaling loop. Oncotarget. 7:6916–6932.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang D, Wang LL, Dong TT, Shen YH, Guo XS,
Liu CY, Liu J, Zhang P, Li J and Sun YP: Progranulin promotes
colorectal cancer proliferation and angiogenesis through TNFR2/Akt
and ERK signaling pathways. Am J Cancer Res. 5:3085–3097.
2015.PubMed/NCBI
|
|
19
|
Wang W, Sun QK, He YF, Ma DC, Xie MR, Ji
CS and Hu B: Overexpression of periostin is significantly
correlated to the tumor angiogenesis and poor prognosis in patients
with esophageal squamous cell carcinoma. Int J Clin Exp Pathol.
7:593–601. 2014.PubMed/NCBI
|
|
20
|
Kawarada Y, Ishikura H, Kishimoto T, Saito
K, Takahashi T, Kato H and Yoshiki T: Inhibitory effects of the
antiangiogenic agent TNP-470 on establishment and growth of
hematogenous metastasis of human pancreatic carcinoma in SCID beige
mice in vivo. Pancreas. 15:251–257. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khan MA, Srivastava SK, Bhardwaj A, Singh
S, Arora S, Zubair H, Carter JE and Singh AP: Gemcitabine triggers
angiogenesis-promoting molecular signals in pancreatic cancer
cells: Therapeutic implications. Oncotarget. 6:39140–39150. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gore J, Craven KE, Wilson JL, Cote GA,
Cheng M, Nguyen HV, Cramer HM, Sherman S and Korc M: TCGA data and
patient-derived orthotopic xenografts highlight pancreatic
cancer-associated angiogenesis. Oncotarget. 6:7504–7521. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pomianowska E, Sandnes D, Grzyb K,
Schjølberg AR, Aasrum M, Tveteraas IH, Tjomsland V, Christoffersen
T and Gladhaug IP: Inhibitory effects of prostaglandin E2 on
collagen synthesis and cell proliferation in human stellate cells
from pancreatic head adenocarcinoma. BMC Cancer. 14:4132014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Georgiadou D, Sergentanis TN, Sakellariou
S, Filippakis GM, Zagouri F, Vlachodimitropoulos D, Psaltopoulou T,
Lazaris AC, Patsouris E and Zografos GC: VEGF and Id-1 in
pancreatic adenocarcinoma: Prognostic significance and impact on
angiogenesis. Eur J Surg Oncol. 40:1331–1337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu XH, Kirschenbaum A, Yao S, Stearns ME,
Holland JF, Claffey K and Levine AC: Upregulation of vascular
endothelial growth factor by cobalt chloride-simulated hypoxia is
mediated by persistent induction of cyclooxygenase-2 in a
metastatic human prostate cancer cell line. Clin Exp Metastasis.
17:687–694. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu XF, Xie CG, Wang XP, Liu J, Yu YC, Hu
HL and Guo CY: Selective inhibition of cyclooxygenase-2 suppresses
the growth of pancreatic cancer cells in vitro and in vivo. Tohoku
J Exp Med. 215:149–157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie C, Wang X, Dong Y, Du Q, Cai J and
Qian K: Effects of selective cyclooxygenase-2 inhibitor celebrex on
the expression of VEGF in pancreatic carcinoma PC-3 cell line.
China Oncol. 13:459–461. 2003.
|
|
28
|
Cheng T, Cao W, Wen R, Steinberg RH and
LaVail MM: Prostaglandin E2 induces vascular endothelial growth
factor and basic fibroblast growth factor mRNA expression in
cultured rat Müller cells. Invest Ophthalmol Vis Sci. 39:581–591.
1998.PubMed/NCBI
|
|
29
|
Jain S, Chakraborty G, Raja R, Kale S and
Kundu GC: Prostaglandin E2 regulates tumor angiogenesis in prostate
cancer. Cancer Res. 68:7750–7759. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mestre JR, Mackrell PJ, Rivadeneira DE,
Stapleton PP, Tanabe T and Daly JM: Redundancy in the signaling
pathways and promoter elements regulating cyclooxygenase-2 gene
expression in endotoxin-treated macrophage/monocytic cells. J Biol
Chem. 276:3977–3982. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lo CJ, Cryer HG, Fu M and Lo FR:
Regulation of macrophage eicosanoid generation is dependent on
nuclear factor kappaB. J Trauma. 45:19–24. 1998. View Article : Google Scholar : PubMed/NCBI
|
